Zimmer Biomet (NYSE:ZBH) Price Target Cut to $130.00

Zimmer Biomet (NYSE:ZBH – Free Report) had its price objective decreased by Truist Financial from $137.00 to $130.00 in a research report released on Friday morning, Benzinga reports. Truist Financial currently has a hold rating on the medical equipment provider’s stock. ZBH has been the topic of a number of other research reports. JPMorgan Chase […]

Related Keywords

United States ,American ,Zimmer Biomet ,Needham Company ,Associates Corp ,Primecap Management Co ,Zimmer Biomet Holdings Inc ,Allspring Global Investments Holdings ,Canaccord Genuity Group ,Jpmorgan Chase Co ,American Century Companies Inc ,Victory Capital Management Inc ,Securities Exchange Commission ,Free Report ,Truist Financial ,Genuity Group ,Biomet Stock Down ,Get Free Report ,Exchange Commission ,Century Companies ,Capital Management ,Global Investments Holdings ,Biomet Holdings ,Zimmer Biomet Daily ,Nyse Zbh ,Zbh ,Medical ,Lower Price Target ,Truist Financial Co ,